nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—breast cancer—colon cancer	0.488	1	CtDrD
Ixabepilone—TUBB4A—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB3—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB2A—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB2B—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB8—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB6—Vincristine—colon cancer	0.0491	0.116	CbGbCtD
Ixabepilone—TUBB1—Vincristine—colon cancer	0.041	0.0974	CbGbCtD
Ixabepilone—TUBB4B—Vincristine—colon cancer	0.041	0.0974	CbGbCtD
Ixabepilone—TUBB—Vincristine—colon cancer	0.041	0.0974	CbGbCtD
Ixabepilone—CYP3A4—Irinotecan—colon cancer	0.002	0.00475	CbGbCtD
Ixabepilone—CYP3A4—Vincristine—colon cancer	0.00175	0.00416	CbGbCtD
Ixabepilone—TUBB3—lymphoid tissue—colon cancer	0.000799	0.042	CbGeAlD
Ixabepilone—TUBB3—digestive system—colon cancer	0.000789	0.0415	CbGeAlD
Ixabepilone—TUBB4A—embryo—colon cancer	0.000774	0.0407	CbGeAlD
Ixabepilone—TUBB1—bone marrow—colon cancer	0.000711	0.0374	CbGeAlD
Ixabepilone—TUBB4B—embryo—colon cancer	0.000603	0.0317	CbGeAlD
Ixabepilone—TUBB4A—renal system—colon cancer	0.000586	0.0308	CbGeAlD
Ixabepilone—TUBB6—epithelium—colon cancer	0.000566	0.0298	CbGeAlD
Ixabepilone—TUBB2B—renal system—colon cancer	0.000566	0.0298	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—colon cancer	0.000556	0.0293	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—colon cancer	0.000553	0.0291	CbGeAlD
Ixabepilone—TUBB6—smooth muscle tissue—colon cancer	0.000546	0.0287	CbGeAlD
Ixabepilone—TUBB6—renal system—colon cancer	0.000525	0.0276	CbGeAlD
Ixabepilone—TUBB4A—lymphoid tissue—colon cancer	0.000486	0.0256	CbGeAlD
Ixabepilone—TUBB4A—digestive system—colon cancer	0.00048	0.0253	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—colon cancer	0.000474	0.025	CbGeAlD
Ixabepilone—TUBB2B—digestive system—colon cancer	0.000464	0.0244	CbGeAlD
Ixabepilone—TUBB4B—renal system—colon cancer	0.000457	0.024	CbGeAlD
Ixabepilone—TUBB2A—digestive system—colon cancer	0.000437	0.023	CbGeAlD
Ixabepilone—TUBB6—lymphoid tissue—colon cancer	0.000436	0.023	CbGeAlD
Ixabepilone—TUBB6—digestive system—colon cancer	0.000431	0.0227	CbGeAlD
Ixabepilone—TUBB2B—vagina—colon cancer	0.00041	0.0216	CbGeAlD
Ixabepilone—TUBB—bone marrow—colon cancer	0.000405	0.0213	CbGeAlD
Ixabepilone—TUBB2A—bone marrow—colon cancer	0.000403	0.0212	CbGeAlD
Ixabepilone—TUBB6—bone marrow—colon cancer	0.000397	0.0209	CbGeAlD
Ixabepilone—TUBB—vagina—colon cancer	0.000388	0.0204	CbGeAlD
Ixabepilone—TUBB2A—vagina—colon cancer	0.000386	0.0203	CbGeAlD
Ixabepilone—TUBB6—vagina—colon cancer	0.000381	0.02	CbGeAlD
Ixabepilone—TUBB4B—lymphoid tissue—colon cancer	0.000379	0.02	CbGeAlD
Ixabepilone—TUBB4B—digestive system—colon cancer	0.000375	0.0197	CbGeAlD
Ixabepilone—TUBB4A—liver—colon cancer	0.000358	0.0188	CbGeAlD
Ixabepilone—TUBB4B—bone marrow—colon cancer	0.000345	0.0182	CbGeAlD
Ixabepilone—TUBB4B—vagina—colon cancer	0.000331	0.0174	CbGeAlD
Ixabepilone—TUBB—liver—colon cancer	0.000327	0.0172	CbGeAlD
Ixabepilone—TUBB2A—liver—colon cancer	0.000325	0.0171	CbGeAlD
Ixabepilone—TUBB6—liver—colon cancer	0.000321	0.0169	CbGeAlD
Ixabepilone—TUBB4B—liver—colon cancer	0.000279	0.0147	CbGeAlD
Ixabepilone—TUBB4A—lymph node—colon cancer	0.000274	0.0144	CbGeAlD
Ixabepilone—TUBB2B—lymph node—colon cancer	0.000265	0.0139	CbGeAlD
Ixabepilone—TUBB—lymph node—colon cancer	0.000251	0.0132	CbGeAlD
Ixabepilone—TUBB2A—lymph node—colon cancer	0.00025	0.0131	CbGeAlD
Ixabepilone—TUBB6—lymph node—colon cancer	0.000246	0.0129	CbGeAlD
Ixabepilone—TUBB4B—lymph node—colon cancer	0.000214	0.0113	CbGeAlD
Ixabepilone—CYP3A4—renal system—colon cancer	0.000188	0.00987	CbGeAlD
Ixabepilone—CYP3A4—digestive system—colon cancer	0.000154	0.0081	CbGeAlD
Ixabepilone—Respiratory failure—Methotrexate—colon cancer	0.000145	0.00202	CcSEcCtD
Ixabepilone—Connective tissue disorder—Vincristine—colon cancer	0.000145	0.00202	CcSEcCtD
Ixabepilone—Urethral disorder—Vincristine—colon cancer	0.000145	0.00201	CcSEcCtD
Ixabepilone—Haemoglobin—Irinotecan—colon cancer	0.000144	0.00201	CcSEcCtD
Ixabepilone—Haemorrhage—Irinotecan—colon cancer	0.000144	0.002	CcSEcCtD
Ixabepilone—Lethargy—Capecitabine—colon cancer	0.000142	0.00197	CcSEcCtD
Ixabepilone—Connective tissue disorder—Irinotecan—colon cancer	0.000141	0.00196	CcSEcCtD
Ixabepilone—Hyponatraemia—Capecitabine—colon cancer	0.00014	0.00194	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000139	0.00193	CcSEcCtD
Ixabepilone—Haemoglobin—Fluorouracil—colon cancer	0.000138	0.00192	CcSEcCtD
Ixabepilone—Haemorrhage—Fluorouracil—colon cancer	0.000138	0.00191	CcSEcCtD
Ixabepilone—Cardiac disorder—Vincristine—colon cancer	0.000137	0.0019	CcSEcCtD
Ixabepilone—Hypoaesthesia—Fluorouracil—colon cancer	0.000137	0.0019	CcSEcCtD
Ixabepilone—Skin exfoliation—Methotrexate—colon cancer	0.000136	0.00189	CcSEcCtD
Ixabepilone—Angiopathy—Vincristine—colon cancer	0.000134	0.00186	CcSEcCtD
Ixabepilone—Cardiac disorder—Irinotecan—colon cancer	0.000133	0.00185	CcSEcCtD
Ixabepilone—Mediastinal disorder—Vincristine—colon cancer	0.000133	0.00185	CcSEcCtD
Ixabepilone—Alopecia—Vincristine—colon cancer	0.00013	0.00181	CcSEcCtD
Ixabepilone—Angiopathy—Irinotecan—colon cancer	0.00013	0.00181	CcSEcCtD
Ixabepilone—Immune system disorder—Irinotecan—colon cancer	0.00013	0.0018	CcSEcCtD
Ixabepilone—Mediastinal disorder—Irinotecan—colon cancer	0.00013	0.0018	CcSEcCtD
Ixabepilone—Dehydration—Capecitabine—colon cancer	0.000129	0.0018	CcSEcCtD
Ixabepilone—Mental disorder—Vincristine—colon cancer	0.000129	0.0018	CcSEcCtD
Ixabepilone—Chills—Irinotecan—colon cancer	0.000129	0.00179	CcSEcCtD
Ixabepilone—Alopecia—Irinotecan—colon cancer	0.000127	0.00177	CcSEcCtD
Ixabepilone—Hypokalaemia—Capecitabine—colon cancer	0.000127	0.00176	CcSEcCtD
Ixabepilone—Sepsis—Methotrexate—colon cancer	0.000124	0.00172	CcSEcCtD
Ixabepilone—Gastritis—Capecitabine—colon cancer	0.000123	0.00171	CcSEcCtD
Ixabepilone—Muscular weakness—Capecitabine—colon cancer	0.000123	0.0017	CcSEcCtD
Ixabepilone—Alopecia—Fluorouracil—colon cancer	0.000122	0.00169	CcSEcCtD
Ixabepilone—Muscle spasms—Irinotecan—colon cancer	0.00012	0.00167	CcSEcCtD
Ixabepilone—Dysphagia—Capecitabine—colon cancer	0.00012	0.00167	CcSEcCtD
Ixabepilone—Anaemia—Vincristine—colon cancer	0.000119	0.00165	CcSEcCtD
Ixabepilone—Angina pectoris—Capecitabine—colon cancer	0.000117	0.00163	CcSEcCtD
Ixabepilone—Anaemia—Irinotecan—colon cancer	0.000116	0.00161	CcSEcCtD
Ixabepilone—Leukopenia—Vincristine—colon cancer	0.000115	0.0016	CcSEcCtD
Ixabepilone—CYP3A4—liver—colon cancer	0.000115	0.00603	CbGeAlD
Ixabepilone—Pancytopenia—Capecitabine—colon cancer	0.000114	0.00159	CcSEcCtD
Ixabepilone—Neutropenia—Capecitabine—colon cancer	0.000112	0.00156	CcSEcCtD
Ixabepilone—Syncope—Irinotecan—colon cancer	0.000112	0.00156	CcSEcCtD
Ixabepilone—Leukopenia—Irinotecan—colon cancer	0.000112	0.00156	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Capecitabine—colon cancer	0.000112	0.00155	CcSEcCtD
Ixabepilone—Anaemia—Fluorouracil—colon cancer	0.000111	0.00154	CcSEcCtD
Ixabepilone—Loss of consciousness—Irinotecan—colon cancer	0.00011	0.00153	CcSEcCtD
Ixabepilone—Myalgia—Vincristine—colon cancer	0.000109	0.00152	CcSEcCtD
Ixabepilone—Cough—Irinotecan—colon cancer	0.000109	0.00152	CcSEcCtD
Ixabepilone—Weight decreased—Capecitabine—colon cancer	0.000109	0.00151	CcSEcCtD
Ixabepilone—Pneumonia—Capecitabine—colon cancer	0.000108	0.0015	CcSEcCtD
Ixabepilone—Leukopenia—Fluorouracil—colon cancer	0.000107	0.00149	CcSEcCtD
Ixabepilone—Infestation—Capecitabine—colon cancer	0.000107	0.00149	CcSEcCtD
Ixabepilone—Infestation NOS—Capecitabine—colon cancer	0.000107	0.00149	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Capecitabine—colon cancer	0.000106	0.00147	CcSEcCtD
Ixabepilone—Lethargy—Methotrexate—colon cancer	0.000106	0.00147	CcSEcCtD
Ixabepilone—Renal failure—Capecitabine—colon cancer	0.000105	0.00146	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Capecitabine—colon cancer	0.000105	0.00146	CcSEcCtD
Ixabepilone—Myocardial infarction—Capecitabine—colon cancer	0.000105	0.00146	CcSEcCtD
Ixabepilone—Oedema—Vincristine—colon cancer	0.000105	0.00146	CcSEcCtD
Ixabepilone—Jaundice—Capecitabine—colon cancer	0.000104	0.00145	CcSEcCtD
Ixabepilone—Stomatitis—Capecitabine—colon cancer	0.000104	0.00145	CcSEcCtD
Ixabepilone—Infection—Vincristine—colon cancer	0.000104	0.00145	CcSEcCtD
Ixabepilone—Urinary tract infection—Capecitabine—colon cancer	0.000104	0.00145	CcSEcCtD
Ixabepilone—Nervous system disorder—Vincristine—colon cancer	0.000103	0.00143	CcSEcCtD
Ixabepilone—Thrombocytopenia—Vincristine—colon cancer	0.000103	0.00143	CcSEcCtD
Ixabepilone—Oedema—Irinotecan—colon cancer	0.000102	0.00142	CcSEcCtD
Ixabepilone—Myalgia—Fluorouracil—colon cancer	0.000102	0.00142	CcSEcCtD
Ixabepilone—Chest pain—Fluorouracil—colon cancer	0.000102	0.00142	CcSEcCtD
Ixabepilone—Infection—Irinotecan—colon cancer	0.000101	0.00141	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Capecitabine—colon cancer	0.000101	0.00141	CcSEcCtD
Ixabepilone—Shock—Irinotecan—colon cancer	0.0001	0.0014	CcSEcCtD
Ixabepilone—Nervous system disorder—Irinotecan—colon cancer	0.0001	0.00139	CcSEcCtD
Ixabepilone—Thrombocytopenia—Irinotecan—colon cancer	0.0001	0.00139	CcSEcCtD
Ixabepilone—Anorexia—Vincristine—colon cancer	9.99e-05	0.00139	CcSEcCtD
Ixabepilone—Hypotension—Vincristine—colon cancer	9.8e-05	0.00136	CcSEcCtD
Ixabepilone—Oedema—Fluorouracil—colon cancer	9.78e-05	0.00136	CcSEcCtD
Ixabepilone—Anorexia—Irinotecan—colon cancer	9.73e-05	0.00135	CcSEcCtD
Ixabepilone—Infection—Fluorouracil—colon cancer	9.71e-05	0.00135	CcSEcCtD
Ixabepilone—Haemoglobin—Capecitabine—colon cancer	9.67e-05	0.00134	CcSEcCtD
Ixabepilone—Haemorrhage—Capecitabine—colon cancer	9.62e-05	0.00134	CcSEcCtD
Ixabepilone—Nervous system disorder—Fluorouracil—colon cancer	9.59e-05	0.00133	CcSEcCtD
Ixabepilone—Thrombocytopenia—Fluorouracil—colon cancer	9.57e-05	0.00133	CcSEcCtD
Ixabepilone—Hypoaesthesia—Capecitabine—colon cancer	9.57e-05	0.00133	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Vincristine—colon cancer	9.55e-05	0.00133	CcSEcCtD
Ixabepilone—Hypotension—Irinotecan—colon cancer	9.54e-05	0.00133	CcSEcCtD
Ixabepilone—Urinary tract disorder—Capecitabine—colon cancer	9.5e-05	0.00132	CcSEcCtD
Ixabepilone—Insomnia—Vincristine—colon cancer	9.48e-05	0.00132	CcSEcCtD
Ixabepilone—Connective tissue disorder—Capecitabine—colon cancer	9.45e-05	0.00131	CcSEcCtD
Ixabepilone—Urethral disorder—Capecitabine—colon cancer	9.43e-05	0.00131	CcSEcCtD
Ixabepilone—Paraesthesia—Vincristine—colon cancer	9.41e-05	0.00131	CcSEcCtD
Ixabepilone—Anorexia—Fluorouracil—colon cancer	9.32e-05	0.0013	CcSEcCtD
Ixabepilone—Insomnia—Irinotecan—colon cancer	9.23e-05	0.00128	CcSEcCtD
Ixabepilone—Paraesthesia—Irinotecan—colon cancer	9.17e-05	0.00127	CcSEcCtD
Ixabepilone—Hypotension—Fluorouracil—colon cancer	9.14e-05	0.00127	CcSEcCtD
Ixabepilone—Decreased appetite—Vincristine—colon cancer	9.11e-05	0.00127	CcSEcCtD
Ixabepilone—Dyspnoea—Irinotecan—colon cancer	9.1e-05	0.00127	CcSEcCtD
Ixabepilone—Erythema multiforme—Capecitabine—colon cancer	9.09e-05	0.00126	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Vincristine—colon cancer	9.05e-05	0.00126	CcSEcCtD
Ixabepilone—Fatigue—Vincristine—colon cancer	9.04e-05	0.00126	CcSEcCtD
Ixabepilone—Eye disorder—Capecitabine—colon cancer	8.99e-05	0.00125	CcSEcCtD
Ixabepilone—Constipation—Vincristine—colon cancer	8.96e-05	0.00125	CcSEcCtD
Ixabepilone—Pain—Vincristine—colon cancer	8.96e-05	0.00125	CcSEcCtD
Ixabepilone—Cardiac disorder—Capecitabine—colon cancer	8.93e-05	0.00124	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Fluorouracil—colon cancer	8.91e-05	0.00124	CcSEcCtD
Ixabepilone—Decreased appetite—Irinotecan—colon cancer	8.87e-05	0.00123	CcSEcCtD
Ixabepilone—Insomnia—Fluorouracil—colon cancer	8.84e-05	0.00123	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Irinotecan—colon cancer	8.81e-05	0.00123	CcSEcCtD
Ixabepilone—Fatigue—Irinotecan—colon cancer	8.8e-05	0.00122	CcSEcCtD
Ixabepilone—Paraesthesia—Fluorouracil—colon cancer	8.78e-05	0.00122	CcSEcCtD
Ixabepilone—Constipation—Irinotecan—colon cancer	8.73e-05	0.00121	CcSEcCtD
Ixabepilone—Pain—Irinotecan—colon cancer	8.73e-05	0.00121	CcSEcCtD
Ixabepilone—Angiopathy—Capecitabine—colon cancer	8.73e-05	0.00121	CcSEcCtD
Ixabepilone—Dyspnoea—Fluorouracil—colon cancer	8.72e-05	0.00121	CcSEcCtD
Ixabepilone—Immune system disorder—Capecitabine—colon cancer	8.69e-05	0.00121	CcSEcCtD
Ixabepilone—Mediastinal disorder—Capecitabine—colon cancer	8.67e-05	0.00121	CcSEcCtD
Ixabepilone—Chills—Capecitabine—colon cancer	8.63e-05	0.0012	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Vincristine—colon cancer	8.57e-05	0.00119	CcSEcCtD
Ixabepilone—Decreased appetite—Fluorouracil—colon cancer	8.5e-05	0.00118	CcSEcCtD
Ixabepilone—Alopecia—Capecitabine—colon cancer	8.5e-05	0.00118	CcSEcCtD
Ixabepilone—Pancytopenia—Methotrexate—colon cancer	8.49e-05	0.00118	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Fluorouracil—colon cancer	8.44e-05	0.00117	CcSEcCtD
Ixabepilone—Mental disorder—Capecitabine—colon cancer	8.43e-05	0.00117	CcSEcCtD
Ixabepilone—Malnutrition—Capecitabine—colon cancer	8.37e-05	0.00116	CcSEcCtD
Ixabepilone—Neutropenia—Methotrexate—colon cancer	8.36e-05	0.00116	CcSEcCtD
Ixabepilone—Pain—Fluorouracil—colon cancer	8.36e-05	0.00116	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Irinotecan—colon cancer	8.35e-05	0.00116	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Methotrexate—colon cancer	8.31e-05	0.00116	CcSEcCtD
Ixabepilone—Abdominal pain—Vincristine—colon cancer	8.29e-05	0.00115	CcSEcCtD
Ixabepilone—Body temperature increased—Vincristine—colon cancer	8.29e-05	0.00115	CcSEcCtD
Ixabepilone—Abdominal pain—Irinotecan—colon cancer	8.07e-05	0.00112	CcSEcCtD
Ixabepilone—Body temperature increased—Irinotecan—colon cancer	8.07e-05	0.00112	CcSEcCtD
Ixabepilone—Muscle spasms—Capecitabine—colon cancer	8.05e-05	0.00112	CcSEcCtD
Ixabepilone—Pneumonia—Methotrexate—colon cancer	8.02e-05	0.00112	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—colon cancer	7.98e-05	0.00111	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—colon cancer	7.98e-05	0.00111	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—colon cancer	7.84e-05	0.00109	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—colon cancer	7.77e-05	0.00108	CcSEcCtD
Ixabepilone—Anaemia—Capecitabine—colon cancer	7.74e-05	0.00108	CcSEcCtD
Ixabepilone—Body temperature increased—Fluorouracil—colon cancer	7.73e-05	0.00107	CcSEcCtD
Ixabepilone—Hypersensitivity—Vincristine—colon cancer	7.72e-05	0.00107	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—colon cancer	7.54e-05	0.00105	CcSEcCtD
Ixabepilone—Hypersensitivity—Irinotecan—colon cancer	7.52e-05	0.00105	CcSEcCtD
Ixabepilone—Asthenia—Vincristine—colon cancer	7.52e-05	0.00105	CcSEcCtD
Ixabepilone—Syncope—Capecitabine—colon cancer	7.51e-05	0.00104	CcSEcCtD
Ixabepilone—Leukopenia—Capecitabine—colon cancer	7.49e-05	0.00104	CcSEcCtD
Ixabepilone—Loss of consciousness—Capecitabine—colon cancer	7.36e-05	0.00102	CcSEcCtD
Ixabepilone—Asthenia—Irinotecan—colon cancer	7.32e-05	0.00102	CcSEcCtD
Ixabepilone—Cough—Capecitabine—colon cancer	7.31e-05	0.00102	CcSEcCtD
Ixabepilone—Hypersensitivity—Fluorouracil—colon cancer	7.2e-05	0.001	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—colon cancer	7.2e-05	0.001	CcSEcCtD
Ixabepilone—Diarrhoea—Vincristine—colon cancer	7.17e-05	0.000997	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—colon cancer	7.16e-05	0.000995	CcSEcCtD
Ixabepilone—Arthralgia—Capecitabine—colon cancer	7.13e-05	0.000991	CcSEcCtD
Ixabepilone—Myalgia—Capecitabine—colon cancer	7.13e-05	0.000991	CcSEcCtD
Ixabepilone—Chest pain—Capecitabine—colon cancer	7.13e-05	0.000991	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	7.08e-05	0.000984	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—colon cancer	7.07e-05	0.000983	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—colon cancer	7.02e-05	0.000976	CcSEcCtD
Ixabepilone—Diarrhoea—Irinotecan—colon cancer	6.99e-05	0.000971	CcSEcCtD
Ixabepilone—Dizziness—Vincristine—colon cancer	6.93e-05	0.000964	CcSEcCtD
Ixabepilone—Pruritus—Fluorouracil—colon cancer	6.92e-05	0.000962	CcSEcCtD
Ixabepilone—Oedema—Capecitabine—colon cancer	6.83e-05	0.00095	CcSEcCtD
Ixabepilone—Infection—Capecitabine—colon cancer	6.79e-05	0.000944	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—colon cancer	6.77e-05	0.000941	CcSEcCtD
Ixabepilone—Dizziness—Irinotecan—colon cancer	6.75e-05	0.000939	CcSEcCtD
Ixabepilone—Shock—Capecitabine—colon cancer	6.72e-05	0.000935	CcSEcCtD
Ixabepilone—Nervous system disorder—Capecitabine—colon cancer	6.7e-05	0.000932	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—colon cancer	6.69e-05	0.00093	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—colon cancer	6.69e-05	0.00093	CcSEcCtD
Ixabepilone—Thrombocytopenia—Capecitabine—colon cancer	6.69e-05	0.00093	CcSEcCtD
Ixabepilone—Vomiting—Vincristine—colon cancer	6.67e-05	0.000927	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—colon cancer	6.64e-05	0.000924	CcSEcCtD
Ixabepilone—Skin disorder—Capecitabine—colon cancer	6.64e-05	0.000923	CcSEcCtD
Ixabepilone—Rash—Vincristine—colon cancer	6.61e-05	0.000919	CcSEcCtD
Ixabepilone—Dermatitis—Vincristine—colon cancer	6.6e-05	0.000918	CcSEcCtD
Ixabepilone—Headache—Vincristine—colon cancer	6.57e-05	0.000913	CcSEcCtD
Ixabepilone—Anorexia—Capecitabine—colon cancer	6.51e-05	0.000906	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—colon cancer	6.5e-05	0.000903	CcSEcCtD
Ixabepilone—Vomiting—Irinotecan—colon cancer	6.49e-05	0.000902	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—colon cancer	6.47e-05	0.000899	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—colon cancer	6.47e-05	0.000899	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—colon cancer	6.45e-05	0.000897	CcSEcCtD
Ixabepilone—Rash—Irinotecan—colon cancer	6.44e-05	0.000895	CcSEcCtD
Ixabepilone—Dermatitis—Irinotecan—colon cancer	6.43e-05	0.000894	CcSEcCtD
Ixabepilone—Chills—Methotrexate—colon cancer	6.42e-05	0.000893	CcSEcCtD
Ixabepilone—Headache—Irinotecan—colon cancer	6.4e-05	0.000889	CcSEcCtD
Ixabepilone—Hypotension—Capecitabine—colon cancer	6.38e-05	0.000888	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—colon cancer	6.33e-05	0.00088	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—colon cancer	6.27e-05	0.000872	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—colon cancer	6.23e-05	0.000867	CcSEcCtD
Ixabepilone—Nausea—Vincristine—colon cancer	6.23e-05	0.000866	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Capecitabine—colon cancer	6.23e-05	0.000866	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—colon cancer	6.22e-05	0.000864	CcSEcCtD
Ixabepilone—Insomnia—Capecitabine—colon cancer	6.18e-05	0.000859	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—colon cancer	6.17e-05	0.000857	CcSEcCtD
Ixabepilone—Dermatitis—Fluorouracil—colon cancer	6.16e-05	0.000856	CcSEcCtD
Ixabepilone—Paraesthesia—Capecitabine—colon cancer	6.14e-05	0.000853	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—colon cancer	6.13e-05	0.000852	CcSEcCtD
Ixabepilone—Dyspnoea—Capecitabine—colon cancer	6.09e-05	0.000847	CcSEcCtD
Ixabepilone—Nausea—Irinotecan—colon cancer	6.06e-05	0.000843	CcSEcCtD
Ixabepilone—Decreased appetite—Capecitabine—colon cancer	5.94e-05	0.000826	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Capecitabine—colon cancer	5.9e-05	0.00082	CcSEcCtD
Ixabepilone—Fatigue—Capecitabine—colon cancer	5.89e-05	0.000819	CcSEcCtD
Ixabepilone—Constipation—Capecitabine—colon cancer	5.84e-05	0.000812	CcSEcCtD
Ixabepilone—Pain—Capecitabine—colon cancer	5.84e-05	0.000812	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—colon cancer	5.81e-05	0.000807	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—colon cancer	5.76e-05	0.000801	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Capecitabine—colon cancer	5.59e-05	0.000777	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—colon cancer	5.58e-05	0.000776	CcSEcCtD
Ixabepilone—Cough—Methotrexate—colon cancer	5.44e-05	0.000756	CcSEcCtD
Ixabepilone—Abdominal pain—Capecitabine—colon cancer	5.4e-05	0.000751	CcSEcCtD
Ixabepilone—Body temperature increased—Capecitabine—colon cancer	5.4e-05	0.000751	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—colon cancer	5.31e-05	0.000738	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—colon cancer	5.31e-05	0.000738	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—colon cancer	5.31e-05	0.000738	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	5.27e-05	0.000733	CcSEcCtD
Ixabepilone—Infection—Methotrexate—colon cancer	5.05e-05	0.000703	CcSEcCtD
Ixabepilone—Hypersensitivity—Capecitabine—colon cancer	5.03e-05	0.0007	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—colon cancer	4.99e-05	0.000694	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—colon cancer	4.98e-05	0.000692	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—colon cancer	4.94e-05	0.000687	CcSEcCtD
Ixabepilone—Asthenia—Capecitabine—colon cancer	4.9e-05	0.000682	CcSEcCtD
Ixabepilone—Anorexia—Methotrexate—colon cancer	4.85e-05	0.000674	CcSEcCtD
Ixabepilone—Pruritus—Capecitabine—colon cancer	4.83e-05	0.000672	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—colon cancer	4.75e-05	0.000661	CcSEcCtD
Ixabepilone—Diarrhoea—Capecitabine—colon cancer	4.68e-05	0.00065	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—colon cancer	4.63e-05	0.000644	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—colon cancer	4.6e-05	0.00064	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—colon cancer	4.57e-05	0.000635	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—colon cancer	4.53e-05	0.00063	CcSEcCtD
Ixabepilone—Dizziness—Capecitabine—colon cancer	4.52e-05	0.000628	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—colon cancer	4.42e-05	0.000615	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—colon cancer	4.39e-05	0.000611	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—colon cancer	4.39e-05	0.00061	CcSEcCtD
Ixabepilone—Pain—Methotrexate—colon cancer	4.35e-05	0.000605	CcSEcCtD
Ixabepilone—Vomiting—Capecitabine—colon cancer	4.34e-05	0.000604	CcSEcCtD
Ixabepilone—Rash—Capecitabine—colon cancer	4.31e-05	0.000599	CcSEcCtD
Ixabepilone—Dermatitis—Capecitabine—colon cancer	4.3e-05	0.000598	CcSEcCtD
Ixabepilone—Headache—Capecitabine—colon cancer	4.28e-05	0.000595	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—colon cancer	4.16e-05	0.000578	CcSEcCtD
Ixabepilone—Nausea—Capecitabine—colon cancer	4.06e-05	0.000564	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—colon cancer	4.02e-05	0.000559	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—colon cancer	4.02e-05	0.000559	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—colon cancer	3.75e-05	0.000521	CcSEcCtD
Ixabepilone—Asthenia—Methotrexate—colon cancer	3.65e-05	0.000507	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—colon cancer	3.6e-05	0.0005	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—colon cancer	3.48e-05	0.000484	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—colon cancer	3.36e-05	0.000468	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—colon cancer	3.23e-05	0.00045	CcSEcCtD
Ixabepilone—Rash—Methotrexate—colon cancer	3.21e-05	0.000446	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—colon cancer	3.2e-05	0.000445	CcSEcCtD
Ixabepilone—Headache—Methotrexate—colon cancer	3.19e-05	0.000443	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—colon cancer	3.02e-05	0.00042	CcSEcCtD
